10.5 C
London
Thursday, March 28, 2024
HomeFinTechGenetic Technologies: Shares explode on new cancer risk assessment test

Genetic Technologies: Shares explode on new cancer risk assessment test

Date:

Genetic Technologies Shares explode on new cancer risk assessment test

  • Genetic Technologies (GTG) launches a new cancer risk assessment test designed to evaluate a woman’s risk of developing breast or ovarian cancer
  • The “world-first” test combines GTG’s GeneType platform with other clinical risk factors to provide a risk assessment result from a single saliva sample
  • GTG CEO Simon Morriss says the test means the company is moving beyond rare cancer-susceptibility genetics to address cancer risk at a population health level
  • The company will first launch the new test in the US and showcase it at the BRCA 2023 Symposium in Montreal in early May
  • Shares in GeneticTechnologies are up 167 per cent to 0.8 cents at 1:27 pm AEDT

Related stories

UK paytech Volopa partners ClearBank to expand its SME banking services

London-based paytech Volopa has partnered with embedded banking...

Digital identity specialist Signicat acquires Icelandic counterpart SmartWorks

Signicat, a European provider of digital identity solutions,...

BNY Mellon deploys AI supercomputer from Nvidia

BNY Mellon, a US-based banking heavyweight, has deployed...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories

spot_img